Which super funds hold Pfizer Netherlands International Finance BV?

As at 31 December 2025, 10 Australian super investment options in our dataset held Pfizer Netherlands International Finance BV, the largest weighting being 0.02% in Diversified Fixed Interest (Accumulation) (AustralianSuper).

Options holding it

10

Largest weighting

0.02%

Diversified Fixed Interest (Accumulation) · AustralianSuper

Funds & options holding Pfizer Netherlands International Finance BV

Australian super investment options disclosing a holding in Pfizer Netherlands International Finance BV. Figures aggregate each option's disclosed line items for this security, as at each option's own reporting date.

FundPhaseOptionWeightingValue (AUD)As at
AustralianSuperAccumulationBalanced (Accumulation)
0.00%
$7,008,61831 December 2025
AustralianSuperRetirementBalanced (Income)
0.00%
$930,05831 December 2025
AustralianSuperRetirementConservative Balanced (Income)
0.00%
$433,14631 December 2025
AustralianSuperAccumulationStable (Accumulation)
0.01%
$379,46631 December 2025
AustralianSuperAccumulationConservative Balanced (Accumulation)
0.00%
$358,84331 December 2025
AustralianSuperRetirementStable (Income)
0.01%
$349,08431 December 2025
AustralianSuperAccumulationDiversified Fixed Interest (Accumulation)
0.02%
$290,03331 December 2025
AustralianSuperAccumulationHigh Growth (Accumulation)
0.00%
$229,97631 December 2025
AustralianSuperRetirementDiversified Fixed Interest (Income)
0.02%
$137,18831 December 2025
AustralianSuperRetirementHigh Growth (Income)
0.00%
$15,42731 December 2025

This page surfaces figures disclosed by the funds themselves under Portfolio Holdings Disclosure (Schedule 8D), each as at the date shown. It is factual disclosure information, not financial advice or a recommendation.

Methodology — how holdings are sourced, resolved and aggregated.

LookThrough shows the actual holdings inside Australian super funds, with cross-fund look-through.

  • 4 of 86 funds
  • 36 of 111 options reviewed
  • 7,010 of 7,168 securities reviewed

© 2026 LookThrough. Factual disclosure information — not financial advice, a rating or a recommendation.